TipRanks
Go Ultimate55% OFF

Santhera Pharmaceuticals Holding (0QN1) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0QN1 Analyst Ratings

There are no analyst ratings in the last 3 months.

0QN1 Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0QN1
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
H.C. WainwrightCHF 30buy96.72%UpsideReiterated07/02/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Santhera Pharmaceuticals Holding

3 Months
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate4/8 ratings generated profit
50%
Average Return
+7.99%

Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +7.99% per trade.

1 Year
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate5/8 ratings generated profit
63%
Average Return
+17.84%

Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +17.84% per trade.

2 Years
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate5/8 ratings generated profit
63%
Average Return
+9.70%

Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +9.70% per trade.

0QN1 Analyst Recommendation Trends

01234Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 0QN1
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy32210
Buy00000
Hold00000
Sell00000
Strong Sell00000
total32210

In the current month, 0QN1 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0QN1 average Analyst price target in the past 3 months is ―.

0QN1 Financial Forecast

CHF -5CHF -3.75CHF -2.5CHF -1.25CHF 0Q2 2025Q2 2026Q4 2026
ConsensusCHF -1.50

0QN1 Earnings Forecast

Next quarter’s earnings estimate for 0QN1 is -CHF 1.50 with a range of ― to ―. The previous quarter’s EPS was -CHF 1.50. 0QN1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0QN1 has Performed in-line its overall industry.

CHF 24MCHF 31.3MCHF 38.6MCHF 45.9MCHF 53.2MQ2 2025Q2 2026Q4 2026
HighCHF 36.9M
ConsensusCHF 36.9M
LowCHF 36.9M

0QN1 Sales Forecast

Next quarter’s sales forecast for 0QN1 is CHF 36.90M with a range of CHF 36.90M to CHF 36.90M. The previous quarter’s sales results were CHF 48.33M. 0QN1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0QN1 has Performed in-line its overall industry.

0QN1 Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Santhera Pharmaceuticals Holding?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Santhera Pharmaceuticals Holding?
To buy shares of GB:0QN1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.